Single peptide Vial strength 5 mg
Ipamorelin5 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Ipamorelin, explained simply
A synthetic pentapeptide investigated for its ability to stimulate endogenous growth hormone release.
Research area
Ghrelin receptor and pituitary response
How it works
Activation of GHSR-1a can produce a pulsatile GH response. In the cited experiments, its hormonal profile differs from other secretagogues.
Why it matters
This allows comparison of hormonal selectivity and response strength without assuming a clinical advantage.
What has been observed
The reported measurements include GH release and experimental findings for ACTH, cortisol and prolactin.
Effects and points to consider
Short-term hormonal measurements do not demonstrate long-term health or body-composition benefits. Formulation and population matter.
01 / Vial strength 5 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg Ipamorelin |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Standard / Gradual Approach (3.0 mL = ~1.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 150 mcg | 9 units (0.09 mL) |
| Weeks 5–8 | 200 mcg | 12 units (0.12 mL) |
| Weeks 9–12 | 250 mcg | 15 units (0.15 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.